Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.
about
Vascular calcification--is aldosterone a culprit?Evolution of treatment strategies for calciphylaxisCalciphylaxis: risk factors, diagnosis, and treatmentCalciphylaxis induced by warfarin therapy in a patient with anti-phospholipid antibody syndrome associated with systemic lupus erythematosus.Statin use and calcific uremic arteriolopathy: a matched case-control study.Calciphylaxis in end-stage renal disease prior to dialytic treatment: a case report and literature reviewPhosphate Metabolism in Cardiorenal Metabolic Disease.Penile lesion in end-stage renal failure - cancer or otherwise?: Calcific uremic arteriolopathy presenting with a penile lesion.Calciphylaxis in a Patient With Alcoholic Cirrhosis.Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.Successful Treatment of Lung Calciphylaxis With Sodium Thiosulfate in a Patient With Sickle Cell Disease: A Case ReportVascular calcification in chronic kidney disease: Pathogenesis and clinical implicationCutaneous manifestations of ESRD.The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.Cardiorenal metabolic syndrome and diabetic cognopathy.Sodium thiosulfate: new hope for the treatment of calciphylaxis.The regulation of valvular and vascular sclerosis by osteogenic morphogensExtraosseous calcification in end-stage renal disease: from visceral organs to vasculature.Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases.Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.Calciphylaxis: from the disease to the diseased.Effect of mitochondrial potassium channel on the renal protection mediated by sodium thiosulfate against ethylene glycol induced nephrolithiasis in rat model.Future research directions to improve fistula maturation and reduce access failure.Sodium thiosulfate as a treatment for calciphylaxis: A case series.A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy.Non Uremic Calciphylaxis Post Liver Transplantation: A Case Report and Literature Review of an Unusual Presentation of a Rare Disease.Ischemic myopathy revealing systemic calciphylaxis.Using Machine Learning Algorithms to Predict Risk for Development of Calciphylaxis in Patients with Chronic Kidney Disease.Multifactorial aetiology for non-uremic calciphylaxis: a case report.Multi-intervention management of calcific uremic arteriolopathy in 24 patients
P2860
Q26851687-BEE559BC-1BA8-4B31-BA00-8529E5F62EACQ27012859-994C8C78-CD2C-4FD5-8119-BDC7DB1A943CQ28084969-BC872BB3-4522-4377-BAE8-3E25D697D45AQ33622254-8645601C-D7DB-4DFB-B8CC-5D7F0EFFDF18Q33948081-90FB8141-55B4-4189-AEF9-B7AC18B3975FQ35100979-76238DD1-981F-4304-8150-0745AEFACFA2Q35546322-6B21A5BE-5CE9-424F-8B60-3674B8D114F7Q35683337-E6F195C8-6B48-4E17-8F5A-F80EC7814568Q35870048-75E5CF28-796E-4D03-A0C1-3D004E68445FQ36580372-0D57E418-06A2-4560-ADC1-E43A97D910C4Q36581102-4264851C-123D-412F-8B56-DB4402E8DE2AQ37195354-35408F27-F513-4520-9A3F-A304967CCE3DQ37426978-205C805B-5329-4C07-AA83-A9FD2AF72E9AQ37495847-C1EF0C5F-C691-4A37-8168-81302B6ABA17Q37514020-84328A7C-1525-4119-8017-FA1205078922Q37773441-709469BC-BBA3-4881-AD26-E85454703D67Q37919693-8F5B723D-C225-48DC-A3DD-04CD0345F18CQ38179484-A6433039-1C12-4A76-B836-B2614E641BA8Q38206770-8A3A8469-833E-491E-B37A-E3172A4253CBQ38306132-3C1C0241-0AAB-4250-B6DE-00E57EBDED8FQ38354900-5FDC63D2-6474-40A9-8805-678F77A73387Q38402043-9A4D0AD7-166C-451F-AE97-C39B11E66B25Q38532123-C28E894F-A17D-4E9B-9BD6-AFA51F5AE8BEQ38646515-13174A7E-8384-4182-991B-16734311F8C3Q39174396-EAAB45B0-EF2E-42A7-B1CF-CDF9E441B1E8Q41191725-7409A1B9-5253-415E-9FF5-91EE50A85539Q44348653-C5DB9219-8A30-4F46-AD72-889471A7452BQ47547707-F6BED311-9B65-47E2-8FC5-52B9DB94DB15Q52946157-48F7EC76-AE0C-4E2C-B024-73BCC4440920Q55048511-EEA11F2D-B300-4D44-9F6A-F0614F7DE27EQ55318175-FEC61A5A-9B17-49E5-9BA5-E9A031291C42Q57053843-80CF9052-F19C-481E-B00F-96BCB89B8C7E
P2860
Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@ast
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@en
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@nl
type
label
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@ast
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@en
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@nl
prefLabel
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@ast
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@en
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@nl
P2860
P921
P356
P1476
Calcific uremic arteriolopathy ...... es and therapeutic approaches.
@en
P2093
Kurt M Sowers
Melvin R Hayden
P2860
P304
P356
10.4161/OXIM.3.2.11354
P577
2010-03-01T00:00:00Z